成人同期与序贯双侧人工耳蜗植入的成本分析:美国单中心研究
该研究基于美国单中心2005–2015年数据,对370例符合双侧植入听力标准的成人进行回顾性成本分析,比较仅单侧植入后部分患者序贯双侧植入(SeqCI)与全部同期双侧植入(SimCI)的直接成本。结果显示,在仅允许SeqCI的机构中,29例患者若按既往趋势有8例(27.3%)进展为SeqCI,总成本为3,482,171.46美元;若全部行SimCI,总成本为3,332,991.75美元,潜在节省149,179.67美元(4.3%)。
要点
- 在仅允许序贯双侧植入的成人机构中,整体管理成本可能略高于同期双侧植入。
- 29例患者中预计8例(27.3%)进展为序贯双侧植入时,总成本较全部同期植入高149,179.67美元(4.3%)。
- 该成本分析基于美国单中心2005–2015年数据,证据等级为4级。
核心结论
- 在仅允许成人序贯双侧人工耳蜗植入的机构中,整体患者管理成本可能略高于若实施同期双侧植入的成本。
研究设计与样本
- 回顾性综述与成本分析,2005–2015年间370例符合双侧植入听力标准的患者,其中267例(72.1%)仅行单侧植入,101例(27.3%)进展为序贯双侧植入,2例行同期双侧植入。
- 成本分析使用2015年8月至2016年8月间29例成人患者的医院、手术、植入物总成本及初始植入刺激系列听力学成本。
主要发现
- 该期间29例患者的医院、手术及植入物总成本为2,731,360.42美元。
- 基于既往本地趋势,若29例中预计8例(27.3%)进展为序贯双侧植入,将额外花费750,811.04美元,29例总成本达3,482,171.46美元。
- 若29例全部行同期双侧植入,预计总成本为3,332,991.75美元,潜在总节省149,179.67美元(4.3%)。
临床怎么用
- 对于仅允许成人序贯双侧植入的机构,需考虑整体患者管理成本可能略高于同期双侧植入模式。
- 该成本信息可供人工耳蜗项目及医疗保险公司参考。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: From a purely surgical efficiency point of view, simultaneous cochlear implantation (SimCI) is more cost-effective than sequential cochlear implantation (SeqCI) when total direct costs are considered (implant and hospital costs). However, in a setting where only SeqCI is practiced and a proportion of initially unilaterally implanted patients do not progress to a second implant, this may not be the case, especially when audiological costs are factored in. We present a cost analysis of such a scenario as would occur in our institution. STUDY DESIGN: Retrospective review and cost analysis. METHODS: Between 2005 and 2015, 370 patients fulfilled the audiological criteria for bilateral implantation. Of those, 267 (72.1%) underwent unilateral cochlear implantation only, 101 (27.3%) progressed to SeqCI, and two underwent SimCI. The total hospital, surgical, and implant costs, and initial implant stimulation series audiological costs between August 2015 and August 2016 (29 adult patients) were used in this analysis. RESULTS: The total hospital, surgical, and implant costs for this period was $2,731,360.42. Based on previous local trends, if a projected eight (27.3%) of these patients decide to progress to SeqCI, this will cost an additional $750,811.04, resulting in an overall total of $3,482,171.46 for these 29 patients. Had all 29 undergone SimCI, the total projected cost would have been $3,332,991.75, representing a total potential saving of $149,179.67 (4.3%). CONCLUSIONS: In institutions where only SeqCI is allowed in adults, overall patient management may cost marginally more than if SimCI were practiced. This will be of interest to CI programs and health insurance companies. LEVEL OF EVIDENCE: 4. Laryngoscope, 127:2615-2618, 2017.
引用
- Trinidade A, Page JC, Kennett SW, et al. Simultaneous versus sequential bilateral cochlear implants in adults: Cost analysis in a US setting. Laryngoscope. 2017. PMID: 28581125. doi:10.1002/lary.26673
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。